Beilstein Journal of Organic Chemistry 2009, 5, No. 63.
5-[4-(6-Bromohexyloxy)phenyl]-2-
octylpyrimidine (3e)
5-[4-(6-Hydroxyhexyloxy)phenyl]-2-
octylpyrimidine (5e)
Prepared according to general procedure (1). Experiment: Prepared according to general procedure (1). Experiment:
284 mg (1.00 mmol) 5-(4-hydroxyphenyl)-2-octylpyrimidine 8, 568 mg (2.00 mmol) 5-(4-hydroxyphenyl)-2-octylpyrimidine 8,
160 μL (245 mg, 1.00 mmol) 1,6-dibromohexane, 168 mg 270 μL (362 mg, 2.00 mmol) 6-bromohexane-1-ol, 336 mg
(3.00 mmol) KOH. Flash chromatography (PE/EtOAc, 4:1, v/v; (6.00 mmol) KOH. Flash chromatography (PE/EtOAc, 1:1, v/v;
Rf = 0.86: PE/EtOAc, 1:1, v/v) gave 268 mg (0.60 mmol, 60%) Rf = 0.29) gave 615 mg (1.60 mmol, 80%) of 5e as a colourless
of 3e as a colourless crystalline solid. DSC: Cr 35 °C [−23.9 kJ/ crystalline solid. Mp: 75 °C. 1H NMR (300 MHz, CDCl3): δ =
mol] (SmA 58 °C [−5.5 kJ/mol]) I. 1H NMR (300 MHz, 0.85–0.90 (m, 3H, CH3), 1.24–1.68 (m, 16H, CH2), 1.79–1.90
CDCl3): δ = 0.88 (t, 3H J = 6.9 Hz, CH3), 1.21–1.45 (m, 10H, (m, 4H, CH2), 2.96–3.01 (m, 2H, 2-CH2), 3.68 (t, 2H, J =
CH2), 1.49–1.58 (m, 4H, CH2), 1.79–1.98 (m, 6H, CH2), 6.5 Hz, CH2OH), 4.01 (t, 2H, J = 6.5 Hz, OCH2), 6.99–7.04 (m,
2.96–3.01 (m, 2H, 2-CH2), 3.44 (t, 2H, J = 6.6 Hz, CH2Br), 2H, 3′-H, 5′-H), 7.46–7.51 (m, 2H, 2′-H, 6′-H), 8.83 (s, 2H,
4.02 (t, 2H, J = 6.4 Hz, OCH2), 6.99–7.03 (m, 2H, 3′-H, 5′-H), 4-H, 6-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3),
7.46–7.50 (m, 2H, 2′-H, 6′-H), 8.83 (s, 2H, 4-H, 6-H) ppm. 22.7, 25.6, 25.9, 28.9, 29.2, 29.5, 31.9, 32.7 (CH2), 39.2
13C NMR (125 MHz, CDCl3): δ = 14.1 (CH3), 22.7, 25.3, 27.9, (2-CH2), 62.8 (CH2OH), 68.0 (OCH2), 115.3 (C-3′, C-5′), 127.9
28.9, 29.0, 29.2, 29.4, 31.9, 32.7, 33.8 (CH2), 39.2 (2-CH2), (C-2′, C-6′), 126.6, 130.8 (C-1’, C-5), 154.5 (C-4, C-6), 159.7
67.9 (OCH2), 115.2 (C-3′, C-5′), 128.0 (C-2′, C-6′), 126.7, (C-4′), 169.6 (C-2) ppm. FT-IR (ATR): = 3303 (m, br), 2917
130.8 (C-1′, C-5), 154.8 (C-4, C-6), 159.9 (C-4′), 169.5 (C-2) (s), 2848 (m), 1606 (m), 1586 (m), 1536 (m), 1516 (m), 1466
ppm. FT-IR (ATR): = 2916 (m), 2848 (m), 1586 (m), 1536 (m), 1445 (s), 1377 (m), 1291 (m), 1288 (m), 1248 (s), 1181
(m), 1515 (m), 1445 (s), 1247 (s), 1180 (m), 1116 (m), 1011 (m), 1118 (m), 1060 (m), 1007 (m), 994 (m), 918 (m), 838 (s),
(m), 994 (m), 838 (s), 651 (m), 608 (m) cm−1. MS (EI, 70eV): 707 (m), 652 (m) cm−1. MS (EI, 70eV): m/z (%) = 384.3 (100)
m/z (%) = 446.1 (100) [M]+, 361.0 (20) [M−C6H13]+, 348.0 [M]+, 299.2 (36), 286.2 (94). HRMS (ESI): m/z [M+H]+ calcd.
(78) [M + H−C7H15], 199.0 (10) 186.0 (28). C24H35BrN2O for C24H37N2O2: 385.2850; found: 385.2856. C24H36N2O2
(447.45): calcd. C 64.42, H 7.88, N 6.26, Br 17.86; found C (384.55): calcd. C 74.96, H 9.44, N 7.28; found C 75.05, H
64.46, H 7.88, N 6.14, Br 17.61.
9.27, N 7.26.
5-[4-(6-Chlorohexyloxy)phenyl]-2-
5-[4-(6-Azidohexyloxy)phenyl]-2-
octylpyrimidine (4e)
octylpyrimidine (6e)
Prepared according to general procedure (1). Experiment: Prepared according to general procedure (2). Experiment:
85.0 mg (0.30 mmol) 5-(4-hydroxyphenyl)-2-octylpyrimidine 8, 224 mg (0.50 mmol)) bromide 3e, 81.0 mg (1.25 mmol) NaN3.
45.0 μL (47.0 mg, 0.30 mmol) 1,6-dichlorohexane, 50.0 mg Flash chromatography (PE/EtOAc, 2:1, v/v; Rf = 0.56) gave
(0.90 mmol) KOH. Flash chromatography (PE/EtOAc, 5:1, v/v; 205 mg (0.50 mmol, quant.) of 6e as a colourless crystalline
Rf = 0.40: PE/EtOAc, 3:1, v/v) gave 74.0 mg (0.18 mmol, 60%) solid. DSC: Cr1 20 °C [−22.2 kJ/mol] Cr2 25 °C [−0.5 kJ/mol]
of 4e as a colourless crystalline solid. DSC: Cr 42 °C [−25.3 kJ/ SmA 58 °C [−5.9 kJ/mol] I. 1H NMR (300 MHz, CDCl3): δ =
mol] SmA 64 °C [−4.5 kJ/mol] I. 1H NMR (300 MHz, CDCl3): 0.85–0.90 (m, 3H, CH3), 1.24–1.58 (m, 14H, CH2), 1.60–1.71
δ = 0.85–0.90 (m, 3H, CH3), 1.23–1.44 (m, 10H, CH2), (m, 2 H, CH2), 1.78–1.91 (m, 4H, CH2), 2.97–3.01 (m, 2H,
1.50–1.55 (m, 4H, CH2), 1.78–1.90 (m, 6H, CH2), 2.96–3.01 2-CH2), 3.30 (t, 2H, J = 6.8 Hz, CH2N3), 4.02 (t, 2H, J = 6.4
(m, 2H, 2-CH2), 3.56 (t, 2H, J = 6.7 Hz, CH2Cl), 4.01 (t, 2H, J Hz, OCH2), 7.00–7.04 (m, 2H, 3′-H, 5′-H), 7.47–7.51 (m, 2H,
= 6.4 Hz, OCH2), 6.99–7.04 (m, 2H, 3′-H, 5′-H), 7.46–7.51 (m, 2′-H, 6′-H), 8.83 (s, 2H, 4-H, 6-H) ppm. 13C NMR (75 MHz,
2H, 2′-H, 6′-H), 8.83 (s, 2H, 4-H, 6-H) ppm. 13C NMR CDCl3): δ = 14.1 (CH3), 22.7, 25.7, 26.5, 28.8, 28.9, 29.1, 29.2,
(75 MHz, CDCl3): δ = 14.1 (CH3), 22.7, 25.4, 26.6, 28.8, 29.1, 29.5, 31.9 (CH2), 39.2 (2-CH2), 51.4 (CH2N3), 67.9 (OCH2),
29.2, 29.4, 31.9, 32.5 (CH2), 39.2 (2-CH2), 45.0 (CH2Cl), 67.9 115.3 (C-3′, C-5′), 127.9 (C-2′, C-6′), 126.7, 130.8 (C-1’, C-5),
(OCH2), 115.3 (C-3′, C-5′), 127.9 (C-2′, C-6′), 126.7, 130.8 154.5 (C-4, C-6), 159.6 (C-4′), 169.6 (C-2) ppm. FT-IR (ATR):
(C-1′, C-5), 154.5 (C-4, C-6), 159.6 (C-4′), 169.6 (C-2) ppm.
= 2921 (s), 2847 (m), 2091 (s), 1605 (m), 1587 (m), 1467
FT-IR (ATR): = 2917 (m), 2849 (m), 1587 (m), 1516 (m), (m), 1446 (s), 1287 (m), 1246 (s), 1182 (m), 1032 (m), 993 (m),
1446 (s), 1392 (m), 1287 (m), 1246 (s), 1181 (m), 1116 (m), 836 (s), 654 (m) cm−1. MS (ESI): m/z = 432.3 [M + Na]+, 410.3
1029 (m), 994 (m), 941 (m), 838 (m), 721 (m) cm−1. MS (ESI): [M + H]+. C24H35N5O (409.58): calcd. C 70.38, H 8.61, N
m/z = 403.3 [M + H]+, 367.3 [M–Cl]+. C24H35ClN2O (403.00): 17.10; found C 70.51, H 8.55, N 17.05.
calcd. C 71.53, H 8.75, N 6.95, Cl 8.80; found C 71.38, H 8.63,
N 6.81, Cl 8.93.
Page 9 of 10
(page number not for citation purposes)